- Projects & figures
- News & Events
- Managing your project
- About ERC
ELECTION SERIES #4
The EU-funded POLCON project aims to understand the impact that the Great Recession has had on the development of political conflict in Europe.
Agnieszka Wykowska is a senior researcher of the Social Cognition in Human-Robot Interaction at the Italian Institute of Technology (Istituto Italiano di Tecnologia) in Genova, Italy. In 2016 she has been awarded an ERC Starting Grant for her project “Intentional Stance for Social Attunement” whose goal is to investigate if humans are ready to engage in social interactions with humanoid robots. Dr Wykowska will present her findings at the ERC's conference Frontier Research and Artificial Intelligence.
ERC grantee Renata Sõukand is exploring to what extent local ecological practices concerning the use of plants, among selected ethnic minorities in Eastern Europe, have declined due to the centralization imposed by dominant practices through the impacts on natural resources, health, economies and the well-being of local communities.
A team of female scientists, including ERC grantee Dr Raffaella Schneider from Sapienza University in Italy found how black holes appeared and grew in the early universe. The lead author of the study was Edwige Pezzulli, a PhD student member of Dr Schneider's ERC-funded team.
Supermassive black holes with masses of about a billion times that of the sun existed by about 12.8 billion years ago.
European researchers have designed brain-like artificial neural networks capable of numerical and spatial cognition and written language processing without any explicit training or pre-programming. Their work, based on the machine-learning approach of generative models, significantly advances the development of self-learning artificial intelligence, while also deepening understanding of human cognition.
Slavery represents a dark and unclosed page in the history of mankind. Even if legally abolished by all countries of the world, its legacies shape the present in a plurality of ways and often overlap with the phenomena that scholars, activists and policy-makers target as new slaveries. Which are the consequences of slavery after its legal death? Should new forms of labor exploitation and human bondage also be read in this key? Or are they the result of recent economic, political and social transformations?
An ERC-funded project is conducting groundbreaking research into a rare form of leukaemia, proving the effectiveness in patients of non-chemotherapy-based treatments that target the genetic cause of the disease. The Hairy Cell Leukemia project, launched by the Institute of Hematology at the University of Perugia in Italy with funding from the European Research Council, is one of the world’s foremost initiatives to develop a targeted therapy for hairy cell leukaemia (HCL), a rare form of blood cancer.
What is the nature of dark energy? How does it relate to dark matter? These are some of the key open questions in cosmology, which Prof. Luigi Guzzo intends to address in his research. Findings of his DARKLIGHT project, funded by the ERC, could add an important piece to the puzzle of the origin and evolution of the Universe.
What do the Velvet revolution, the transitions in Baltic countries in the 1990s and the Gezi Park protests in Istanbul have in common? Prof. Donatella Della Porta is leading an ambitious project to compare the most relevant democratization processes led by social movements of the last 25 years.
For the first time ever, two ERC grantees, Prof. Luca G. Guidotti and Dr Matteo Iannacone, have observed in vivo how specific white blood cells, so-called cytotoxic T lymphocytes, identify, target and attack liver cells that are infected with the hepatitis B virus. To witness these immune cells in action in real time, the two scientists developed advanced, dynamic imaging techniques. An estimated 240 million people are chronically infected with hepatitis B worldwide. This discovery, published today in the scientific journal Cell, opens new horizons for the development of novel therapies.